A clinico-patholgical survey was made on a series of 123 ovarian tumors operated upon at National Medical Center, Seoul, Korea.
The results obtained are as follows:
1) The incidence of benign tumors was 84.6% of all ovarian tumors while that of malignant ones 15.4%.
2) Age distribution of all :ovarian tumors as well as benign tumors was concentrated on the --ages between 36-40(average 38.5 years), malignant one on the ages between 56-60(average 42.5 years)
3) 68.3%, of all ovarian tumors had regular menstrual cycles and 16.2% of them had irregularly to some extent; benign tumors showed 71,1% of regular:, cycles and 16.3% of irregular ones while in malignat ones they were 52.6% and 15.8%, respectively.
4) As -to the subjective symptoms of all ovarian tumors, palpable mass in the lower abdomen was noticed´ in 69.1%, lower abdominal pain in 52.0% and backache in 22;7%, respectively.
5) Ascites were observed in 5 cases(4.8%), cachexia in 4 cases(3.1%). In malignat cases ascites and cacheexia were noted in 26.3% and 10.5%, while in benign cases none had ascites a d cachectic only 1.6%.
6) Among the benign tumors the incidence of pseudomucinous cystadenomas was 32.6%, that of dermoid cysts 30.7% and that of, serous cystadenomas 27.8%.. Of malignat tumors serous papillary cystadenocarcinomas were 26.3%, pseudomucinous cystadenocarcinomas 15.8%.
7) Bilaterality of dermoid cysts was noted in 18.7%, that of serous cystadenomas 3.5% and that of peudomicinous cystadenomas 2.9%.
8) Serous cystadenocarcinomas were obseved twice as frequently as pseudomicinous ones.
9) Malignancy of serous type was observed in 14.7%, while that of pseudomucinous type 8.1% and that of dermoid 3%.
10) Three out of 9 cases of cystic carcinoma were bilateral while all 5 cases of primary, solid, carcinoma were unilateral.
11) In cytic carcinma, bilateral occrrence was observed in one of 3 cases of pseudmucinous cystadenocarcinoma, and also in one of 5 cases of serous papillary cystadenocarcinoma.
12) The malignancy in serous neoplasms, pseudomucinous ones and dermoid tumors occurred in 14.7 %, 8. 1%, and 3.0%, respectively.
|